CoChat

Early supplementation with Lactobacillus rhamnosus HN 001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?

Wickens, K., Stanley, T. V., Mitchell, E. A., Barthow, C., Fitzharris, P., Purdie, G., Siebers, R., Black, P. N., Crane, J. · 2013 · Clinical & Experimental Allergy
Cited by 117

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Summary: Background: The role of probiotics in prevention of allergic disease is still not clear; efficacy may depend on the timing, dose, duration, and specific probiotic used. Using a double‐blind randomized placebo‐controlled trial (Australian New Zealand Clinical Trials Registry: ACTRN 12607000518460), we have shown that in a high‐risk birth cohort, maternal supplementation from 35 weeks gestation until 6 months if breastfeeding and infant supplementation from birth until 2 years with Lactobacillus rhamnosus HN 001 ( HN 001) (6 × 10 9 cfu/day) halved the cumulative prevalence of eczema at 2 and 4 years. Bifidobacterium animalis subsp lactis HN 019 ( HN 019) (9 × 10 9 cfu/day) had no significant effect. Objective: To determine whether differences in effects of HN 001 and HN 019 on eczema persist to age 6 years, and to investigate effects on sensitization. Methods: Standard procedures were used to assess eczema (The UK Working Party's Criteria), eczema severity ( SCORAD ), atopic sensitization [skin prick tests ( SPT ), total and specific IgE] and standard questions used for asthma, wheeze, and rhinoconjunctivitis. Results: HN 001 was associated with significantly lower cumulative prevalence of eczema ( HR = 0.56, 95% CI 0.39–0.80), SCORAD ≥ 10 ( HR = 0.69, 0.49–0.98) and SPT sensitization ( HR = 0.69, 95% CI 0.48–0.99). The point prevalence of eczema ( RR = 0.66, 95% CI 0.44–1.00), SCORAD ≥ 10 ( RR = 0.62, 95% CI 0.38–1.01) and SPT sensitization ( RR = 0.72, 95% CI 0.53–1.00) were also reduced among children taking HN 001. HN 019 had no significant effect on any outcome. Conclusion and Clinical Relevance: This study provides evidence for the efficacy of the probiotic L. rhamnosus HN 001 in preventing the development of eczema and possibly also atopic sensitization in high risk infants to age 6 years. The absence of a similar effect for HN 019 indicates that benefits may be species specific.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cea.12154

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 117

Metadata

Authors
Wickens, K., Stanley, T. V., Mitchell, E. A., Barthow, C., Fitzharris, P., Purdie, G., Siebers, R., Black, P. N., & Crane, J.
Venue
Clinical & Experimental Allergy
Publisher
Wiley
Published
2013-08-20
Volume
43
Issue
9
Pages
1048-1057
ISSN
  • 0954-7894 (ISSN-L)
  • 1365-2222
OpenAlex
W2145934766
Cited by
117
References
5
FWCI
17.95
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early supplementation with Lactobacillus rhamnosus HN 001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? https://app.cochat.ai/papers/10.1111/cea.12154
The paper
Wickens, K., Stanley, T. V., Mitchell, E. A., Barthow, C., Fitzharris, P., Purdie, G., Siebers, R., Black, P. N., & Crane, J. (2013). Early supplementation with Lactobacillus rhamnosus HN 001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clinical & Experimental Allergy. https://doi.org/10.1111/cea.12154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.